Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Digitalis
|
| gptkbp:activities |
inhibits Na+/ K+ AT Pase
|
| gptkbp:affects |
heart rate
cardiac contractility electrical conduction in the heart |
| gptkbp:appointed_by |
healthcare professional
injection oral tablet |
| gptkbp:brand |
Crystodigin
|
| gptkbp:can_be_used_with |
gptkb:ACE_inhibitors
diuretics beta-blockers |
| gptkbp:caused_by |
fatigue
confusion arrhythmias hypokalemia headaches hyperkalemia bradycardia |
| gptkbp:composed_of |
sugar moiety
steroid nucleus |
| gptkbp:contraindication |
ventricular fibrillation
hypersensitivity to digitoxin |
| gptkbp:developed_by |
gptkb:Digitalis_lanata
|
| gptkbp:discovered_by |
gptkb:19th_century
|
| gptkbp:financial_performance |
potassium levels
|
| gptkbp:first_introduced |
foxglove plant
|
| https://www.w3.org/2000/01/rdf-schema#label |
digitoxin
|
| gptkbp:ingredients |
C41 H64 O13
|
| gptkbp:is_atype_of |
C01 A A04
|
| gptkbp:is_available_on |
prescription medication
|
| gptkbp:is_monitored_by |
therapeutic drug monitoring
|
| gptkbp:is_part_of |
heart failure management
atrial fibrillation management |
| gptkbp:is_subject_to |
drug interactions
dose adjustments toxicity monitoring |
| gptkbp:is_used_for |
gptkb:atrial_fibrillation
heart failure |
| gptkbp:is_used_in |
cardiology
|
| gptkbp:lifespan |
5 to 7 days
|
| gptkbp:metabolism |
liver
|
| gptkbp:related_to |
gptkb:digoxin
|
| gptkbp:requires |
patient education
regular blood tests monitoring of symptoms |
| gptkbp:side_effect |
nausea
vomiting diarrhea visual disturbances |
| gptkbp:suitable_for |
pregnant women
breastfeeding women patients with thyroid disorders patients with renal impairment elderly patients with multiple comorbidities |
| gptkbp:type_of |
20830-75-5
|